“ Since its establishment, BioSingapore has increased its membership and now has more than 100 associated individuals and around 30 member companies. ”
In Conversation
“ We spend 5.1% of our GDP on health care, while the OECD countries spend an average of 9.3%. ”
“ We see ourselves as filling the space between academic research in the universities and the corporate research that takes place in industry ”
“ Singapore is an attractive investment destination, especially for the biomedical sector, because it has sophisticated infrastructure, a relevantly skilled workforce, great logistical connectivity to regional markets,… ”
“ Singapore is an attractive investment destination, especially for the biomedical sector, because it has sophisticated infrastructure, a relevantly skilled workforce, great logistical connectivity to regional markets,… ”
“ [The US-Singapore FTA] remains the gold standard for modern free trade agreements, not just for the United States and Singapore, but anywhere in the world, ”
HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore.…
In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore…
Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more…
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name…
The merger with Invitrogen-Applied Biosystems in 2008 was a big milestone for the company. As one of the leaders of this integration, can you please explain…
In the past two years Life Technologies has been investing in Singapore— last year you opened a regional distribution center in Singapore’s Tuas Biomedical Park and…
